RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @DukeHFDoc: Really nice overview of critical challenges in HfpEF led by @DrKishanParikh https://t.co/28CL1gXt6e
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
Really nice overview of critical challenges in HfpEF led by @DrKishanParikh
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @DrWillWatson: https://t.co/wnCU9uMRsa Report based on a 2017 consensus meeting- have we moved beyond these questions? (imho) HFpEF is n…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @DrWillWatson: https://t.co/wnCU9uMRsa Report based on a 2017 consensus meeting- have we moved beyond these questions? (imho) HFpEF is n…
https://t.co/wnCU9uMRsa Report based on a 2017 consensus meeting- have we moved beyond these questions? (imho) HFpEF is not uniform and needs individually targeted trials! (and isn't just about inflammation) #cardioed #hfpef @mkonstam @JJheart_doc https://
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
Looking forward to reading this today!
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
【雑記】今回のJACC HFはHFpEF特集。 https://t.co/Fk7v7Y2PDH
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
RT @paomorejon: • #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great revi…
• #HeartFailure With Preserved EF Expert Panel Report Current Controversies and Implications for Clinical Trials Great review • #InsuficienciaCardiaca con Fey preservada Excelente revisión #cardioed #FOAMed #cardiotwitter By @JACCJournals @ACCinTouch h
RT @coconnormd: JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67v…
JACC-HF : First expert panel report on HFpEF: Future directions in a condition without a specific therapy https://t.co/67vadLORzB
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
RT @JTLLERGO: Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Tria…
Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials @secardiologia @SACardiologia @ValleAlfonso @DrDoblas @doctorchecho @Gontxi7 https://t.co/fDbjJDkkYB https://t.co/bdTGBTlvgv